About Allevi
Allevi is a company based in Philadelphia (United States) founded in 2014 by Ricky Solorzano was acquired by 3D Systems in May 2021. It operates as a Direct-to-Consumer (D2C). Allevi has raised $3.58 million across 5 funding rounds from investors including 3D Systems, Penn Medicine and 500 Global. Allevi offers products and services including Allevi 3D Bioprinters and Bioinks. Allevi operates in a competitive market with competitors including Nuclera Nucleics, CELLINK, Aspect Biosystems, OxSyBio and Collplant, among others.
- Headquarter Philadelphia, United States
- Founders Ricky Solorzano
-
Sectors
HealthcareTechnology
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Allevi, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$3.58 M (USD)
in 5 rounds
-
Latest Funding Round
$1 M (USD), Seed
Oct 30, 2019
-
Investors
3D Systems
& 5 more
-
Employee Count
Employee Count
-
Acquired by
3D Systems
(May 06, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Allevi
Allevi offers a comprehensive portfolio of products and services, including Allevi 3D Bioprinters and Bioinks. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Advanced bioprinters are offered for 3D tissue engineering.
Various bioinks are provided for tissue-specific bioprinting applications.
Unlock access to complete
Software Development Team
86 people
Sales and Marketing
30 people
Leadership Team
29 people
Senior Team
20 people
Product Management Team
17 people
Finance and Accounting
8 people
Legal and Compliance
8 people
Operations Team
7 people
Unlock access to complete
Funding Insights of Allevi
Allevi has successfully raised a total of $3.58M across 5 strategic funding rounds. The most recent funding activity was a Seed round of $1 million completed in October 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Seed — $1.0M
-
First Round
First Round
(22 Oct 2014)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2019 | Amount | Seed - Allevi | Valuation |
investors |
|
| Nov, 2017 | Amount | Seed - Allevi | Valuation |
investors |
|
| Sep, 2015 | Amount | Seed - Allevi | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Allevi
Allevi has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include 3D Systems, Penn Medicine and 500 Global. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital and acceleration are provided to tech startups.
|
Founded Year | Domain | Location | |
|
Startup accelerator
|
Founded Year | Domain | Location | |
|
Technology ecosystem growth is supported in Southeastern Pennsylvania.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Allevi
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Allevi
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Allevi Comparisons
Competitors of Allevi
Allevi operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Nuclera Nucleics, CELLINK, Aspect Biosystems, OxSyBio and Collplant, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Desktop bioprinter for genes and proteins production is developed.
|
|
| domain | founded_year | HQ Location |
3D bioprinters and bioinks are developed for research applications.
|
|
| domain | founded_year | HQ Location |
Bioprinting technology and tissue therapeutics for regenerative medicine are developed.
|
|
| domain | founded_year | HQ Location |
Provider of 3D printing of tissue biomaterials for medical research and clinical applications
|
|
| domain | founded_year | HQ Location |
Plant-derived collagen is developed for tissue repair and 3D bioprinting.
|
|
| domain | founded_year | HQ Location |
Developer of integrated 3D printing and tissue-engineering platform
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Allevi
Frequently Asked Questions about Allevi
When was Allevi founded?
Allevi was founded in 2014.
Where is Allevi located?
Allevi is headquartered in Philadelphia, United States. It is registered at Philadelphia, Pennsylvania, United States.
Who is the current CEO of Allevi?
Ricky Solorzano is the current CEO of Allevi. They have also founded this company.
Is Allevi a funded company?
Allevi is a funded company, having raised a total of $3.58M across 5 funding rounds to date. The company's 1st funding round was a Seed of $1.25M, raised on Oct 22, 2014.
What does Allevi do?
Allevi, part of 3D Systems since 2021, is focused on delivering advanced 3D bioprinting technologies and materials. Solutions are developed for tissue engineering, organ-on-a-chip, and disease modeling. Their bioprinters and bioinks are utilized by researchers globally to address challenges in regenerative medicine, drug discovery, and clinical research. Applications are supported across sectors like cancer biology, vaccine development, and stem cell therapeutics.
Who are the top competitors of Allevi?
Allevi's top competitors include Nuclera Nucleics, Aspect Biosystems and Collplant.
What products or services does Allevi offer?
Allevi offers Allevi 3D Bioprinters and Bioinks.
Who are Allevi's investors?
Allevi has 6 investors. Key investors include 3D Systems, Penn Medicine, 500 Global, Dreamit, and Ben Franklin Technology Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.